Home » Newsletters » BioWorld Science

BioWorld Science

June 11, 2007

View Archived Issues

New treatment options for inflammatory disorders disclosed in recent patents

New therapeutic agents for metabolic disorders reported in recent patents

Tetrathiomolybdate well tolerated in idiopathic pulmonary fibrosis

Quadrivalent papillomavirus vaccine prevents vulvar and vaginal lesions

New ghrelin receptor ligands show antiobesity properties by increasing energy expenditure

CUV-1647 begins phase III trial in erythropoietic protoporphyria

GlaxoSmithKline and Biovitrum terminate program in obesity

Phosphagenics awarded AusIndustry grant for TPM-02

Iomai updates development of adjuvant patch

APT in-licenses inhalable form of ciclosporin for lung transplant rejection

Abbott and Caprion extend discovery partnership in oncology

Androxal shows significant positive effects in men with secondary hypogonadism

Studies comparing zolpidem oral spray to Ambien meet objectives

New therapeutic option for glaucoma reported in recent Solvay patent

ROX-888 provides effective pain relief following major abdominal surgery

Fujirebio receives new patent for HE4 biomarker with utility in ovarian cancer

Genomic Health reports new data for Oncotype DX breast cancer assay

Novel Ras inhibitor has promising activity and safety in hematological malignancies

Encouraging phase I results obtained for sapacitabine in hematological cancers

Data presented at ASCO for AEZS-108, a targeted cytotoxic-LHRH conjugate

Interim analysis of phase II clinical trials on XL-999

TroVax alone or combined with IL-2 or interferon effective and safe in renal cell carcinoma

Indibulin capsule formulation well tolerated and potentially active in solid tumor patients

Atacicept associated with stable disease at well-tolerated doses in B-CLL

Novel LFA-1/ICAM-1 interaction inhibitors claimed in recent patent

Avastin launched in Japan for colorectal cancer

BLA submission completed for IL-Trap in CAPS

Arixtra launched in Japan

Japanese launch for Adoair

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...